Publications by authors named "Amy Praestgaard"

Claim this Profile
O
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis.
Sonja Ständer, Gil Yosipovitch, Brian S Kim, Martin Steinhoff, April Armstrong, Amy H Praestgaard

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials.
Brian S Kim, Margarida Gonçalo, Tsukasa Ugajin, Xing-Hua Gao, Amy H Praestgaard

Am J Clin Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison.
Sonja Ständer, Andreas Pinter, Firas G Hougeir, Patricia Guyot, Yingxin Xu, Amy H Praestgaard

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD).
Robert Bissonnette, Elena Goleva, Evgeny Berdyshev, Shannon Garcia, Marco Ramirez-Gama, Amy H Praestgaard

J Am Acad Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Meaningful Changes in Patient-Reported Outcome Measurement Information System-Fatigue Scores from Three Phase 3 Clinical Trials of Sarilumab for Patients With Rheumatoid Arthritis.
Clifton O Bingham, Emily Molina, Amy Praestgaard, Stefano Fiore, David Cella

ACR Open Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Amy S Paller, Andreas Pinter, Lara Wine Lee, Roland Aschoff, Jacek Zdybski, Amy Praestgaard

Adv Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trial.
Wytske J Fokkens, Claus Bachert, Claire Hopkins, Osama Marglani, Amy Praestgaard

Clin Transl Immunology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52.
Claus Bachert, Asif H Khan, Stella E Lee, Claire Hopkins, Anju T Peters, Amy Praestgaard

Int Forum Allergy Rhinol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Amy S Paller, Andreas Pinter, Lara Wine Lee, Roland Aschoff, Jacek Zdybski, Amy Praestgaard

Adv Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry.
Jeffrey R Curtis, Huifeng Yun, Lang Chen, Stephanie S Ford, Hubert van Hoogstraten, Amy Praestgaard

Rheumatol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Claus Bachert, Tanya M Laidlaw, Seong H Cho, Joaquim Mullol, Brian N Swanson, Amy Praestgaard

Ann Otol Rhinol Laryngol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle study.
Faeq Husain-Syed, Matthew F DiFrancesco, Rajat Deo, R Graham Barr, Julia J Scialla, Amy Praestgaard

Clin Kidney J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry.
Jeffrey R Curtis, Huifeng Yun, Lang Chen, Stephanie S Ford, Hubert van Hoogstraten, Amy Praestgaard

Rheumatol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab.
Ernest Choy, Vivian Bykerk, Yvonne C Lee, Hubert van Hoogstraten, Kerri Ford, Amy Praestgaard

Rheumatology (Oxford)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis.
Carsten Flohr, Alan D Irvine, Michael J Cork, Eric L Simpson, Andreas Wollenberg, Amy Praestgaard

Br J Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
Thomas Huizinga, Ernest Choy, Amy Praestgaard, Hubert van Hoogstraten, Patrick R LaFontaine

Rheumatol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement or Worsening of Disease Activity After Switch to Sarilumab in Patients With Rheumatoid Arthritis With a Partial Response to Adalimumab.
Jeffrey R Curtis, Daniel Aletaha, Gerd Burmester, Kerri Ford, Hubert van Hoogstraten, Amy Praestgaard

J Clin Rheumatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
Yoshiya Tanaka, Toshiya Takahashi, Hubert Van Hoogstraten, Amy Praestgaard, Naoto Kato

Clin Exp Rheumatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry.
Nancy Shadick, Owen Hagino, Amy Praestgaard, Stefano Fiore, Michael Weinblatt

Arthritis Res Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey).
Amy S Paller, Stephan Weidinger, Korey Capozza, Andrew E Pink, Mark Tang, Amy Praestgaard

Dermatol Ther (Heidelb)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard

J Asthma Allergy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies.
Jorge F Maspero, Claus Bachert, Fernando J Martinez, Nicola A Hanania, Benjamin Ortiz, Amy Praestgaard

J Asthma Allergy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.
Evgeny Berdyshev, Elena Goleva, Robert Bissonnette, Irina Bronova, Anna Sofia Bronoff, Amy Praestgaard

Allergy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab.
Andrea Rubbert-Roth, Daniel E Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk

Arthritis Res Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.
Claus Bachert, Asif H Khan, Claire Hopkins, Michael S Blaiss, Zachary M Soler, Amy Praestgaard

J Asthma Allergy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis